










































Expert perspectives on ethics review of international data-
intensive research
Citation for published version:
Dove, ES & Garattini, C 2018, 'Expert perspectives on ethics review of international data-intensive research:
Working towards mutual recognition' Research Ethics, vol 14, no. 1, pp. 1-25. DOI:
10.1177/1747016117711972, 10.1177/1747016117711972




Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.




© The Author(s) 2017




Expert perspectives on ethics 
review of international  
data-intensive research: 
Working towards mutual 
recognition
Edward S Dove
University of Edinburgh, UK
Chiara Garattini
Intel Corporation, Health and Life Sciences, London, UK
Abstract
Life sciences research is increasingly international and data-intensive. Researchers work in 
multi-jurisdictional teams or formally established research consortia to exchange data and 
conduct research using computation of multiple sources and volumes of data at multiple sites 
and through multiple pathways. Despite the internationalization and data intensification of 
research, the same ethics review process as applies to single-site studies in one country tends 
to apply to multi-site studies in multiple countries. Because of the standard requirement for 
multi-jurisdictional or multi-site ethics review, international research projects are subjected 
to multiple ethics reviews of the same research protocol. Consequently, the reviews may be 
redundant and resource-consuming, whilst the opinions delivered by ethics committees may 
be inconsistent both within and across jurisdictions. In this article, we present findings based 
on interviews conducted with international experts in research ethics on the topic of ethics 
review mutual recognition. We explore the issues associated with ethics committee review 
of multi-jurisdictional data-intensive research projects, identifying current problems, real-life 
experiences, and potential solutions that are both bottom-up (via researchers, participants 
and publics) and top-down (via statutory regulation), as well as challenges in achieving both. 
On the whole, participants recommended multiple changes to the current ethics review 
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regime for data-intensive international research with the aim of reducing inefficiency and 
inconsistency. But, the changes recommended differ in terms of degree and scope. In general, 
participants stressed that key drivers of success in a reformed system should be strong 
leadership (on the ground and in government) and demonstration of value.
Keywords
data-intensive research, ethics review, international research, mutual recognition, research 
ethics, research ethics committees
Introduction
Research ethics guidelines recommend that multi-jurisdictional research be evalu-
ated by research ethics committees (RECs) in all relevant jurisdictions, or indeed 
at all sites where the proposed study will take place (Coleman et al., 2015). The 
rationale for this approach is that it reflects regulatory requirements for REC 
review in each jurisdiction, and, from a policy and normative perspective, that 
RECs in each site or jurisdiction are best attuned to ‘local sensitivities’, reflecting 
the socio-legal environment of the local site. It is assumed that, among other 
things, risk and benefit assessment, consent procedures, local population recruit-
ment strategy, knowledge of laws and regulations, and understandings of research 
participants’ rights and interests are best placed in a localized expert body rather 
than through some other arrangement that could neglect these local issues. 
Moreover, from a historical perspective, most life sciences research was interven-
tional and conducted on only a few participants by individual researchers at a local 
institution. In such a context, local knowledge of both researcher and study popu-
lation could be important (Stark, 2012). The historical impetus and underlying 
normative rationales have endured. Consequently, many countries’ regulatory and 
policy instruments require local REC review for multi-jurisdictional research.
Yet, there is long-standing recognition that the research ethics review system is 
operating sub-optimally internationally and in many areas of research (Dove 
et al., 2014, 2016; Klitzman, 2015; Schneider, 2015; Stark, 2012; van den 
Hoonaard and Hamilton, 2016). Because of the requirement for local REC review, 
research projects engaging multiple sites are subjected to multiple ethics reviews 
of the same research protocol. Consequently, the reviews may be redundant and 
resource-consuming. The opinions delivered by RECs, however, are often not 
redundant; rather, they are inconsistent (Abbott and Grady, 2011; Angell et al., 
2006; Resnik, 2014; Vadeboncoeur et al., 2016). Because each REC may have 
distinct rules, forms, procedures and practices for review, divergent opinions out-
side a range of reasonableness can result. Replicate REC reviews have not been 
shown to improve the quality of participants’ well-being and could indeed inhibit 
important research (Dove et al., 2016). The issue is particularly challenging in 
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international data-intensive research projects,1 which, compared to intervention-
ist clinical research on humans (e.g. clinical trials or trials involving medical 
devices) that raises risks of physical harm, instead often raise different ethical 
concerns that require different assessment. In data-intensive research, data can be 
collected from consenting participants at one site, but often they are stored, ana-
lysed or linked with other datasets elsewhere; it is not unusual for storage, analy-
sis and linkage to occur for indefinite periods of time and at multiple sites or 
databases around the world. Based on the limited empirical research that exists, 
divergent REC opinions are at least partially a consequence of lack of training 
and expertise in the ethics of data-intensive science (Lemke et al., 2011).
The coordination of international data-intensive research projects thus raises 
important practical challenges for the regulatory framework of research ethics 
review. This is a timely topic to explore because research involving humans is 
increasingly international, indirect (as it is more data-intensive) and complex 
(Kaye et al., 2012). Researchers work in multi-jurisdictional project teams or 
formally established research consortia to recruit data-providing participants (or 
work with already-collected datasets) and conduct research at multiple sites. A 
question arises as to whether there are multi-jurisdictional (i.e. international) 
work-arounds or solutions for the challenges associated with REC reviews 
at each site or jurisdiction for a data-intensive research project. On this point, 
academics recently have called for more empirical research to guide policies 
that seek to institute alternative ethics review models for multicentre studies 
(Ervin et al., 2015).
Substantively addressing this issue is the objective of the Ethics Review 
Equivalency (ERE) Task Team of the Global Alliance for Genomics and Health 
(GA4GH), of which the authors are members.2 The GA4GH is an international 
non-profit organization of over 1000 individual and organizational members 
whose mission is to accelerate the international sharing of genomic and clinical 
data to improve human health. The ERE Task Team is exploring several innova-
tive ethics review tools, especially ‘mutual recognition’ of ethics review between 
RECs for international data-intensive research projects. Mutual recognition can be 
defined as the acceptance by RECs of the outcome of each other’s review such that 
further (full) local ethics review is unnecessary. We exclude work in the clinical 
trials domain, which is led foremost by the International Council for Harmonisation 
of Technical Requirements for Pharmaceuticals for Human Use (ICH). As mem-
bers of the GA4GH, we believe that if society is to maximize the potential of 
modern computing power that gathers individual, patient and population data into 
large datasets, linking them to enable precision medicine, we must move beyond 
the current system that emphasizes independent and siloed local ethics review to 
one that works with all stakeholders to develop models for mutual recognition 
between RECs. Such models, supported by ongoing dialogue with a wide range of 
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stakeholders and shared policies, guidance and frameworks, could facilitate ethi-
cal research, clarify the processes of evaluating data-intensive research projects, 
and better balance the interests of science, society and data-providing research 
participants.
In this article, we present findings from a qualitative research project in which 
we explore the issues associated with REC review of multi-jurisdictional data-
intensive research projects, identifying current problems, real-life experiences, 
potential work-arounds and challenges therein. To our knowledge, no similar pro-
jects have been undertaken and reported in the literature. The driving research 
questions for this project were to explore what problems (if any) arise in REC 
review of multi-site and multi-jurisdictional data-intensive research projects, how 
these problems can be effectively addressed through both bottom-up solutions (e.g. 
via researchers, participants and publics) and top-down solutions (e.g. via statutory 
regulation), and what challenges the potential solutions themselves may create.
Methods
Semi-structured interviews
Qualitative research was seen as the best approach to learn about specific case 
studies – that is, real-life examples of international research projects that encoun-
tered RECs in multiple jurisdictions – and uncover what those experiences were 
like, and whether any key lessons were learnt. One-on-one, semi-structured inter-
views allowed us to gather experts’ in-depth, detailed points of view and to explore 
real-life processes of multi-jurisdictional ethics review. Semi-structured inter-
views were also seen as the best method to converse with people to get a sense of 
their lived world as a stakeholder in research ethics and, together with the inter-
viewee, produce practical knowledge about multi-jurisdictional ethics review 
(Arksey and Knight, 1999; Brinkmann and Kvale, 2015; Ritchie and Lewis, 2003). 
Further, conversing with experts in the field of research ethics review was seen as 
a beneficial method to draw out insights and perceptions into research ethics over-
sight, as well as to gather insight on and interpret the problems of international 
ethics review and uncover potential solutions to those problems. The goal of this 
project, as in many qualitative research projects, was not to obtain statistical rep-
resentation, but rather to obtain theoretical representation to reflect particular fea-
tures of the sample population of research ethics review experts.
Interview guide design
As these interviews were semi-structured, an interview guide was designed. 
Interviewing people identified as ‘experts’ meant that the questions had to assume 
a baseline of significant knowledge about research ethics review. After outlining a 
brief introductory statement on the research project, emphasizing confidentiality 
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and confirming consent to audio-record and transcribe the interview, the inter-
viewer (the first author: ESD) asked for brief background information of the inter-
viewee, including their involvement in ethics review and a summary of their current 
activities. The interview then proceeded to explore three broad topics as follows.
The objective of the first section was to learn about the interviewee’s experience 
with multi-jurisdictional research projects. We hoped to draw out rich information 
about a particular case study or two, where possible – letting the interviewee select 
a project considered relevant, and then deep-diving into it. The objective of the 
second section was to learn about some of the possible general problems encoun-
tered in multi-jurisdictional ethics review. We wished to know if participants 
viewed the current system as a ‘problem’ and, if so, why – and what kinds of 
‘problems’ they identified in particular. The objective of the third section was to 
determine whether participants were aware of any ‘work-around’ solutions to the 
perceived problems (if they identified any problems), either based on their own 
experiences with research projects or through general awareness. We also wanted 
to broach different models the ERE Task Team had developed, including three 
emerging models (reciprocity, delegation, federation) of ethics review mutual rec-
ognition (Dove et al., 2016)3 and receive feedback from participants regarding the 
feasibility and support of these models.
Sampling, selection and analysis
Prior to recruitment, ethics approval was obtained from the Edinburgh Law School 
Research Ethics and Integrity Committee. We then engaged in strategic sampling 
(Mason, 2002) to identify individuals (a) who could speak to multi-jurisdictional 
ethics review from different jurisdictional perspectives, and (b) who had experi-
ence with a particular research methodology (i.e. data-intensive research), whilst 
(c) also keeping in mind the project’s resource limitations. Ease of access also 
drove the sampling strategy. Therefore, we also used convenience sampling and, 
after the initial interviews, snowball sampling, to select further participants with 
the aim to be representative of various global regions (Patton, 2002).
Twenty-five individuals, of the twenty-nine contacted, responded and agreed to 
be interviewed in English. All but two of the interviews were conducted via Skype; 
the other two interviews were conducted in person. These 25 individuals came from 
different jurisdictions that reflect different socio-legal and research environments. 
Several participants were also current or past REC members themselves. Whilst 
there is some overlap, the professional and geographic distributions by continent 
are reflected in Table 1. Table 2 provides the specific country and interview ID of 
each participant. The average interview time was 57 minutes (ranging from 35 min-
utes to 82 minutes). Interviews were audio-recorded with a digital recorder; audio 
files of the interviews were professionally transcribed in intelligent verbatim and 
then checked against the recordings. Transcripts were manually coded using 
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Table 2. Country representation of each participant.

































Research organization/clinical practice 6
Government/policy/regulatory authority 6







Dove and Garattini 7
qualitative thematic analysis, which offers theoretical freedom and flexibility to 
yield rich and detailed, yet complex, accounts of data (Braun and Clarke, 2006).
Limits
Our qualitative research project has some limitations. First, we interviewed only 
individuals we identified as ‘experts’ (which we took to mean academics, regula-
tors or policy-makers, and life sciences researchers) in research ethics and data-
intensive research. This therefore excluded perspectives from other critical actors 
such as participants and researchers in other domains who could offer additional 
insight into problems, challenges and solutions relating to ethics review of interna-
tional data-intensive research. As our research focused on the perspectives of 
experts in the field of data-intensive research, the views expressed may not be rep-
resentative of those in another research context. However, some participants felt 
more comfortable discussing other areas of research, such as clinical trials, and 
therefore our findings may have resonance outside the confines of data-intensive 
research as we define it. Second, the framing of our research project and several of 
the interview questions may have meant that those who had a particular story to tell 
or a particular interest in ethics review were more likely to share their insights of 
perceived problems and work-arounds. Third, Canada is somewhat overrepresented 
in our sample, largely due to the snowball sampling method. Although we believe 
that our Canadian participants offered insightful perspectives on navigating ethics 
review in a federal country and in a country known for its strong data-intensive and 
internationally collaborative research environment, it is unknown how this distribu-
tion would compare to other countries in terms of density of research activity or 
experience with ethics review problems and the solutions associated with mutual 
recognition. Finally, although qualitative data provide valuable insight into concep-
tually nuanced topics such as ethics review, our findings are not externally general-
izable per se. This said, we believe our thematic findings can generate ‘theoretical 
generalisability’ (Mason, 2002); in other words, they can be used to generate 
hypotheses and queries for subsequent investigation.
Results
Participants communicated to us that although there are multiple problems in the 
current ethics review system, there are also many possible solutions (ranging from 
the procedural to the substantive) to improve the status quo and/or achieve some 
status of ethics review mutual recognition. Thus, systemic reform can occur at dif-
ferent levels and in different ways, which often reflected the local socio-political 
and legal context of the interviewee’s location. Nonetheless, participants felt that 
there are various challenges in attempting to reform the ethics review system, 
including through the solutions they identified.
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In the remainder of this section, we unpack the problems, challenges and solu-
tions identified by the participants.
Problems
All participants stressed that the current system in place for reviewing the ethical 
acceptability of international data-intensive research suffers from problems that 
impact the system’s efficiency and robustness. Indeed, participants identified over 
25 distinct issues they considered to be ‘problems’ with the current system (either 
stated explicitly as a ‘problem’ or through use of a similar term). The underlying 
thread in all the distinct problem areas identified is the notion of systemic ineffi-
ciency and substantive weakness reflected, for example, in apprehension to novel 
or emerging forms of science, a focus on tick-box procedures, and a lack of rea-
soned, principled decisions. Notions of systemic inefficiency and substantive 
weakness were grounded in concerns regarding variability, inconsistency and 
duplication. In large part, this is due to jurisdictional diversity in a number of 
areas, including: the legal basis for RECs; the number of RECs; procedures for 
appointment of REC members; the composition of RECs; quality assurance of 
RECs; conflicts of interest; liability of RECs; assessment of multicentre studies; 
interaction with authorities; financial support; and systems of appeal. As we out-
line below, the foremost stated problem centred around variability and inconsist-
ency of ethics reviews, which was often attributed to lack of communication 
between RECs (especially across jurisdictions), and to REC members lacking 
expertise in data-intensive science domains such as genomics.
Variability, inconsistency and duplication. Not surprisingly, given its common pres-
ence in the empirical literature (e.g. Angell et al., 2006; Caulfield et al., 2011; 
Ferguson and Master, 2016), participants frequently expressed concern about the 
amount of variability and inconsistency in decisions or opinions rendered by RECs 
across sites within the same jurisdiction or across several jurisdictions. Partici-
pants also criticised the duplication of ethics reviews, leading to bureaucracy and 
significant time delays in research projects. The general sentiment expressed was 
that RECs conduct the same kind of review based on the same project, leading to 
waste. Participants emphasized this point well by referencing their own difficult 
experience with multi-jurisdictional or multi-site research projects even within 
their own country, either as a project manager or member of a REC:
We submitted [our application] to ten sites and we had ten hospitals in [an Australian state], we 
needed to submit … this is our [research] protocol back in 2007/2008. We wanted to get this up 
and running within a year, knowing it would probably take us that long to get all the protocols 
sorted out, so we still had to fill in the local 12-page documented questions that were relevant 
to whatever local ethics committee. (ERE25)
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Participants found it unclear what the additional reviews contributed by way of eth-
ics rather than local site-specific governance issues (distinct from ethics issues) 
such as investigator competence, data retention policies or local population recruit-
ment. For instance, ERE21 from Uganda discussed how his country reformed its 
ethics system in 2014 in response to this problem, such that one REC now can issue 
a country-wide opinion for multi-site research conducted in the country. This inter-
viewee characterized the reforms as responses to inconsistency and duplication.
Lack of communication. Lack of communication between RECs, especially across 
multiple jurisdictions, was identified by participants as a cause of inefficiency and 
variability in the system. If RECs fail to adequately communicate with one another, 
it is difficult for them trust each other, much less have insight into the decision 
rendered by another REC on the same research project (and the reasons thereof), 
and for RECs to learn about best practices from one another. Some participants 
expressed frustration that much knowledge about the ethics of data-intensive 
research is not shared across jurisdictions, and that REC administration is detached 
from the deep scholarship on research ethics generally. Others commented that it 
is difficult for RECs to view the opinions rendered by other RECs. Because the 
underlying reasons are not commonly shared (particularly outside the country), an 
internationally shared body of knowledge cannot easily be built.
Lack of expertise. As mentioned above, another cause of systemic inefficiency and 
variability identified by several participants was that REC members lack sufficient 
training or expertise, especially with respect to understanding the issues associated 
with data-intensive science, including the challenges it presents to traditional 
notions of ‘specific’ consent and the need to link data to multiple datasets – pos-
sibly in other jurisdictions – for research discovery. Participants found that, speak-
ing of RECs generally, there is a crucial role for training of REC members 
(particularly in research ethics and data-intensive science) and for REC members 
to have a good orientation as to what their mandate is. Some RECs, particularly in 
lower-and-middle-income countries (LMICs), were seen as apprehensive to 
emerging or ‘grey’ areas of science such as genomics, in part due to either the lack 
of any regulation or guidance in the subject area, or regulatory restrictiveness that 
thwarted the REC’s ability to be innovative in their review processes.
Challenges
Despite the many problems identified in the current system, participants suggested 
innovative work-arounds (as discussed below in the section on Solutions), but 
often whilst simultaneously acknowledging challenges in trying to reform the sta-
tus quo. Indeed, participants listed more than 30 distinct challenges, which are 
grouped into several categories discussed below. The common underlying thread 
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across the identified challenges was the difficulty in building trust between RECs 
such that each could rely on the review undertaken and decision made by another.
Local context and sensitivity. By far the most significant challenge identified was the 
pervasive notion of locality, specifically local context and sensitivities. Likewise, 
the literature is replete with discussion about the importance (or not) of local knowl-
edge and decision-making (e.g. Barchi et al., 2014; Klitzman, 2015; Wainwright 
and Saunders, 2004). Several participants noted that it is difficult to involve local 
communities in ethics review processes in a meaningful way, and to assume that 
RECs can adequately represent such sensitivities. Further, some participants pointed 
out that there is disparity between the ethics review system in the Western world, 
where governments and research institutions have invested heavily in operational 
resources and professional staff to assist RECs, and the ethics review system in 
LMICs, which remains understaffed, under-resourced and largely under-informed 
about emerging data-intensive science areas such as genomics.
Local context was a hybrid concept in our research findings: some thought it to 
be an insurmountable challenge to systemic reform; others thought it also to be a 
current ‘problem’ in the system that caused inefficiency. Few thought it could be 
addressed with a clear solution. For example, ERE6 found that, in her years work-
ing in international research consortia, local sensitivities were important, if diffi-
cult, to acknowledge:
… the questions that come out of an individual country often times take you by surprise. ‘Oh, 
that’s what you worry about’, or, ‘Gosh, you know, I hadn’t thought about that’ … You just don’t 
know what’s important to a country, if I can use that as a kind of a global setting, or even peoples 
within a country. It’s completely different and harmonization is blooming difficult when it 
comes to that kind of thing. You just have to spend a lot of time finding out what is important to 
different groups.
Participants felt that there are vast cultural differences between RECs, reflecting 
in part how different laws or policies govern the ethics review process. Participants 
from Europe further stressed that linguistic differences between countries can 
affect the style of communication, and that the nature of ethics review is very 
much linked to the way one deliberates on ethics issues.
Some participants noted the tremendous cultural variation even within the 
same country. ERE10, for example, commented that the REC in the Ghanaian 
capital city, Accra, might not ‘necessarily understand the local culture and some 
of the traditions that might influence research participation [in other parts of 
Ghana], some of the issues that people might have about participating in genetic 
and genomic studies’. For this reason, she felt that local RECs were likely to 
identify pertinent ethical issues better than a distant REC ‘because of the close-
ness of the committee to the research site and also to the research participants’, 
but she conceded that they ‘haven’t tested this in any way to see whether it is 
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really the case’. She felt that a ‘joint ethics review’ in Ghana is possible, ‘as 
long as the local ethics committee is not left out’ in order ‘to still get those 
inputs from someone who would be able to bring these local perspectives to the 
review process’. ERE10 mentioned this could be done through a community 
representative participating in the joint review, but as ERE21 from Uganda 
noted, defining a ‘community representative’ is a difficult endeavour (espe-
cially in an intensely varied culture environment such as many places in Africa), 
and it remains unclear how and whether this approach can be scaled up beyond 
just one country or region.
Others, however, questioned whether local context and sensitivity was really an 
insurmountable challenge, and whether it was more rhetoric than reality:
The thing that I’m always puzzled [about local context and sensitivity], though, is that if that’s 
the claim, where’s the evidence? … It becomes a procedural difference rather than a substantive 
difference. I don’t think it’s defensible to maintain procedural differences because it’s just that 
you do things slightly differently. Well, that’s just a nonsense to say that that should stand in the 
way of a more efficient review. (ERE4)
Similarly, ERE3 stated: ‘I think it’s a bit of a mistake and fantasy to believe that 
those committees are actually functioning only as local representatives of their 
institution. They’re not.’ Some participants described local context and sensitivity 
as a ‘nightmare’ for reforming the system, but felt it was a ‘cloak’ that REC mem-
bers and others often hide under as an excuse to avoid thinking about systemic 
reform. These participants felt that the issue was really about trying to maintain 
local (i.e. specific REC) precedent and control rather than local sensitivity, an 
observation that has been evidenced in the empirical literature on RECs (e.g. 
Klitzman, 2015; Stark, 2012).
Attitude and power dynamics. Participants suggested that institutions, RECs and 
members thereof are reluctant to cede power and authority to another REC and 
therefore could pose an obstacle to any model seeking to streamline ethics review. 
Some spoke of both anxiety and attitude issues amongst REC members because of 
uncertainty whether they will make the ‘right’ decision, or because they think their 
decision will be ‘more right’ than other RECs. In the opinion of these participants, 
RECs have always been bodies of power that control research and thus are reluc-
tant to move towards a system of ethics review mutual recognition where they 
have to cede some control and thereby trust the review of another REC:
Every REB thinks that they do the best job or that they are the ones that nobody can review it 
the way that they do. It’s a little bit of an ego and it plays into it. Also there’s the general feeling 
that, well, if we’re not seen as an REB that could be the REB of Record, then we’re going to 
lose our share of the research or we’re going to lose the caché that’s associated with having a 
‘qualified’ research ethics board. (ERE16)
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ERE7 stated that accreditation systems, whilst a possible solution to improving the 
overall quality of RECs, could also exacerbate power dynamics, either because 
non-accredited RECs are viewed as untrustworthy or because even accredited 
RECs feel that they must always take charge of reviewing a research protocol in 
order to maintain their accreditation standing.
Another important power issue concerns the relationship between the Western 
world and LMICs. Participants, particularly from the African continent, raised con-
cerns about double standards (e.g. an expectation that Western RECs might have to 
be ‘recognized’ by African ones, but not the other way around), and wondered 
whether RECs at different institutions in previously disadvantaged areas of a coun-
try or region would follow due diligence in making decisions. In this context, 
emphasis was placed on the importance of trusting that the research enterprise will 
promote the interests of local patients, participants and researchers; and querying 
whether international research collaboration in fact will lead to further extraction of 
resources from LMICs rather than actually lead to significant building of research 
and health capacity. Thus, these participants commented that any proposal to intro-
duce or develop an international system for ethics review mutual recognition in the 
LMIC context would have to inspire confidence that it appropriately recognizes the 
need to reduce global health inequalities and global health injustice.
Regulatory complexity, jurisdictional politics and sovereignty. Systemic reform of ethics 
review is challenged by the extant laws and politics within each jurisdiction. Not 
only do jurisdictional politics and sovereignty present challenges to designing 
models of mutual recognition, complex or restrictive regulations also can make 
delegation or centralization of review cumbersome or illegal (i.e. creating poten-
tial regulatory liability). Participants recalled situations where they had engaged in 
discussions with RECs in other jurisdictions to query whether they could do a 
‘facilitated review’ (i.e. forego further full committee review and rely on a full 
committee review done by one REC), but ultimately could not, ostensibly because 
of jurisdictional issues such as regulations requiring that full committee review be 
done by one or several RECs in their own jurisdiction.
Participants noted that some regulatory frameworks concerning, for instance, 
privacy and data protection, require ethics reviews be conducted in the local juris-
diction, preventing reliance on or delegation to reviews conducted elsewhere. Some 
lamented the additional, non-ethics-related roles imposed on RECs (e.g. acting as a 
privacy overseer for an institution) that make shifting to a non-local ethics review 
model challenging. Because of the challenge of regulatory complexity (or restric-
tiveness) and sovereignty, many stressed the importance of having a regulatory 
authority at the highest level of government – if not international authorities such 
as the World Health Organization (WHO) – to push for change and endorse the 
legality of reliance on reviews conducted by RECs in trusted jurisdictions. Others, 
however, held little faith in the ability of regulatory authorities, national councils or 
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governments, or supranational unions to push for ethics review mutual recognition. 
For these participants, actors at this level are not necessarily the right actors to 
facilitate systemic change.
There is a further challenge in constitutional politics reflected in the composi-
tion of certain countries. Participants in Canada and Australia noted that because 
health is governed at the provincial/state level, there was a gap in leadership in 
pushing for federated or centralized ethics review across the entire country, much 
less outside it. At the same time, the federal government has to respect the politics 
of the provinces/states to prevent encountering resistance:
I think it’s always difficult to do things nationally, to tell people what to do … Anything you do 
federally has to come in respecting what’s happening in those provinces and taking the attitude, 
‘how can we facilitate and help this, what can we do to make things work and improve things 
across the country?’ If you come in with, ‘we’re going to coordinate all of you’, that’s not 
working. It’s not going to work. (ERE18)
Some participants observed that jurisdictional sovereignty and local law impact on 
all areas, inside and outside life sciences research, and present significant chal-
lenges to harmonization. This is not to say that participants considered ethics 
review harmonization to be impossible as opposed to challenging. Rather, many 
stressed that harmonization – that is, working towards mutual recognition of ele-
ments of a robust and trustworthy ethics review and similar processes – should be 
distinguished from global ‘standardization’ that could, for example, impose a sin-
gle consent template or research protocol template worldwide, in addition to the 
multiple (and wildly differing) templates that already exist (Jackson and Larson, 
2016) which could create or exacerbate liability concerns in each country.
Solutions
Despite the many problems, participants suggested multiple solutions to reform the 
system, even if some carried challenges themselves. Quite often, participants quali-
fied their discussion of potential solutions by advocating two overarching tenets: (i) 
the need to demonstrate value (i.e. show that a different way of conducting a multi-
jurisdictional review is beneficial for different stakeholders); and (ii) the need to 
have leadership from both the bottom up (e.g. within specific projects or institu-
tions) and top down (e.g. within regulatory agencies or government ministries). 
Most of the solutions identified by participants can be grouped into the categories 
of improved communication, harmonization and operational planning, as follows.
Improved communication (frequency and platform). Many participants spoke of the need 
to bring various stakeholders together, ideally in-person (but also possibly through 
internet web fora), to talk through the issues and explore alternative arrangements for 
multi-jurisdictional ethics review. The suggestions ranged from holding face-to-face 
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meetings among RECs a few times a year to discuss scientific questions, legal ques-
tions and ethical questions to determine if there are discrepancies and different opin-
ions among RECs, to more established arrangements for sharing of information 
among RECs, which is seen by some as a prerequisite to creating a more centralized 
or coordinated ethics review system. Several recommended having a much stronger 
forum for dialogue about ethics, and engaging all institutions involved in research, as 
both are seen as an essential step towards achieving mutual recognition.
Harmonization. Participants suggested various ways of harmonizing processes of 
ethics review. This included developing a so-called ‘placemat’ where a common eth-
ics review form (with sublayers of guidance) is provided for REC members when 
conducting reviews. It also included fostering associations for RECs that could run 
training programmes, drafting guidance documents and establishing fora for RECs 
to build trust in each other. This exists in some jurisdictions already. For example, 
the UK’s Health Research Authority has created a common ‘ethical review form’ for 
National Health Service REC members to consult when undertaking reviews (Health 
Research Authority, 2015). Others suggested that regulatory authorities (or some 
other competent body) create and disseminate model (i.e. template) reciprocity 
agreements for RECs to use, ideally for establishing reciprocity across jurisdictions 
and not just within. Still others suggested that countries try to harmonize (but not 
standardize in a formulaic way) their definitions of key terms such as a ‘research 
database’, as well as the governance arrangements for RECs that address issues such 
as composition of committees and how the reviews should be undertaken. Such har-
monization would cater to some cultural variation to avoid making the ethics dia-
logue between members and committees artificial, but nonetheless firm up trust in 
the reviews undertaken by other RECs in other jurisdictions.
Operational planning. Operational planning, or due diligence of various operational 
aspects before launching a new model of ethics review (be it federated or dele-
gated arrangements), was viewed by many as crucial both for establishing the 
legitimacy of an alternative model (e.g. a newly established central REC or a REC 
that has been tasked with reviewing on behalf of others), and for maintaining the 
model’s success. ‘Operational planning’ as discussed by participants often trans-
lated into money, a regulatory mandate, space, staff (i.e. administrative support), a 
secretariat and software (including common online IT platforms for sharing infor-
mation seamlessly, including perhaps with a standardized research application 
form). To establish meaningful ethics review mutual recognition, the first step 
according to many is to focus on implementation, developing interoperable infra-
structures (such as shared software) and building the processes into the already-
developed administrative processes for each institution.
Another interviewee also felt ‘ethics review equivalence alone is not enough’ and 
that the importance of the operational aspects of any streamlining initiative could not 
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be stressed enough (ERE14). She referenced the initiative undertaken by the Canadian 
province of Quebec, which has instituted a more streamlined ethics review model 
since 1994. However, it was not until the province implemented a recently revised 
multi-centre model with a complete infrastructure surrounding it that improvements 
in efficiencies started to be noted on the ground and in collected data metrics. Thus, 
ERE14, along with others, stressed that in promoting greater efficiencies in multi-
jurisdictional REC review, it is crucial to deliberate and even pilot test a model or 
arrangements beforehand to determine how it might work (or not work) in practice.
Bottom-up approaches. Participants, particularly those sceptical of systemic change 
being led from the top through government, thought that significant change in the 
near term more likely would come from the bottom up, where international research 
projects can build a critical mass of data to develop several good case studies of 
successful implementation of mutual recognition. Through these case studies, fur-
ther pilot studies could be tested that would further accumulate data to lead to evi-
dence-based policy for governments to then implement on a systemic level. 
Participants thus suggested ‘starting small’ in developing mutual recognition. Each 
jurisdiction (e.g. a province, state or country) could work towards having a single 
ethics review for the whole jurisdiction – some said ideally on a voluntary basis to 
foster greater support – and then building up from there eventually between two 
countries and then beyond. By starting small, evidence can be gathered and, through 
an iterative process, improve the mutual recognition model(s).
Regulatory endorsement and accreditation. Even though many participants felt that 
systemic change gradually would be led by projects on the ground and expressed 
some scepticism about political leadership, many equally felt that there was a criti-
cal role to be played by governments, regulatory authorities or similar bodies, 
policy-makers and research leaders. The common sentiment was that both ele-
ments were needed: bottom-up at the REC and administrative level, and top-down 
from senior research leaders and government. Some even went further and advo-
cated new legislation to change the current system. For example, ERE6 referenced 
the 2002 EU Clinical Trials Directive as an example of successful legislative 
change that overhauled the UK’s previously much-maligned REC system, most 
notably by instituting a single UK-wide ethics opinion for most health-related 
research. According to her: ‘It’s the only way. It was the [Directive] that really 
drove something a little bit more formal here in the UK, and people being fed up 
with not being able to get any work done.’ Similarly, ERE23 said that the best way 
to reform the system, at least in the EU, was for new EU legislation to be passed, 
as ‘it is important to find those solutions and perhaps committees also need to be 
in a sense forced to accept a more international system’.
More participants, however, spoke in favour of regulatory endorsement of 
alternative models rather than new legislation. That is, they advocated facilitation 
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rather than strict coordination. Specifically, they highlighted that regulatory 
authorities could endorse a mutual recognition model (or several) to give it regu-
latory legitimacy and thus mitigate concerns of regulatory liability. ERE2, who 
was otherwise sceptical about the ability of governments or regulatory authorities 
(or national research councils) to articulate clear guidelines that empower mutual 
recognition, was nevertheless confident that other multinational entities, such as 
the African Academy of Sciences, could take ‘greater ownership’ over some of 
the discussions around data-intensive research (e.g. genomics) and ethics review 
mutual recognition on the African continent.
Some thought that national regulatory authorities could work together to establish 
international systems of accreditation, qualification or certification of RECs to 
encourage mutual trust in each other’s processes of review. ERE21, for instance, 
found that the accreditation system created in Uganda in 2009 vastly improved prob-
lems of ethics review capacity, consistency and logistics in the country. But whilst 
some participants saw accreditation (or a similar approach) as a useful step towards 
establishing mutual trust in RECs, others were cautious in touting its benefits. As 
one stated: ‘What’s the problem we’re trying to solve? Because if you ask the folks 
in Quebec, they’ve had a kind of accreditation system of [RECs] since 1994, but it 
hasn’t helped with efficiency and getting reviews faster until they’ve actually put a 
mechanism in place to support the infrastructure and the actual operations’ (ERE14). 
The concern from several participants was that accreditation could actually exacer-
bate a tick-box mentality where RECs merely follow the regulations, and following 
regulations does not necessarily mean that the REC is protecting participants any 
better. Thus, they emphasized caution in advocating too strong a top-down approach 
in imposing ethics accreditation. As there is as yet no sound evidence that shows 
accreditation alone better protects participants or improves the efficiency of ethics 
reviews, several participants advocated a ‘staged approach’ to establishing a base-
line quality or standard in reviews and then moving toward full accreditation only if 
there is sufficient evidence to do so. Nonetheless, participants felt that it should be 
possible to work towards an agreement for equivalent protection.
Mutual recognition models. Participants were supportive of ethics review mutual 
recognition models discussed in a recent article (Dove et al., 2016), namely the 
delegated model (also known as a ‘REC of Record’ model), the reciprocity model 
(often conducted through bilateral reciprocity agreements or MOUs between insti-
tutions), and the federated model of ethics review. In this latter model, which was 
the most commonly cited by participants, institutions, funders or regulators/gov-
ernments create through agreement a central, specifically formulated multi-juris-
dictional REC (which could be comprised of REC representatives of each involved 
site). The agreement may state that the multi-jurisdictional REC assumes compli-
ance functions and adheres to internationally recognized ethics policies as well as 
applicable regulatory requirements. The multi-jurisdictional REC could manage 
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the liability of local institutions (e.g. through several or proportionate liability or 
‘no fault’ insurance schemes) (Townend et al., 2016). The agreement may also 
stipulate agreed-upon principles, forms, operating procedures and standards that 
allow for robust ethical scrutiny and continuing review. One option is that local 
sites may provide input on site-specific matters to the multi-jurisdictional REC, 
and the ethics review opinion provided by the multi-jurisdictional REC may be 
accepted or rejected by all participating local sites.
Participants often advocated this model more than others, for various reasons. 
Some suggested that reciprocity agreements between institutions can be impracti-
cal (as they govern relationships between only two or several institutions rather 
than entire jurisdictions), and that a ‘REC of Record’ (i.e. delegation of full 
review to a single REC) model could present challenges where not all sites are 
involved in projects (hence it would be more ad hoc) or in similar ways, and 
therefore there can be resistance to having everything go to one REC and not oth-
ers. A federated REC comprised of the leading experts from various regions in 
data-intensive science, or even a variation of this, such as a ‘joint REC’ with joint 
chairs and members of two or more institutions, was seen as a promising approach 
to addressing concerns of local context, both reducing duplicative reviews and 
building trust amongst RECs, institutions and jurisdictions. Some thought that 
this model could be pilot-tested in one jurisdiction and then scaled up, depending 
on the evidence of success. As ERE10 told us: ‘An ideal situation would be a kind 
of joint review, where if the project is going to be conducted at three sites in 
Ghana, then some members of the three committees could come together and 
conduct a joint review of that project, instead of letting it go through all the 
IRBs.’ This interviewee added that it would be important for such a REC to still 
receive input from an individual who could bring local perspectives to the review 
process. However, other participants acknowledged challenges in a federated 
REC model, including membership composition and the potential loss of, rather 
than recognition of, ‘local sensitivities’.
Discussion
Almost all participants spoke of the regime of multi-jurisdictional ethics review as 
being comprised of interconnected problems, challenges and solutions set within 
overarching themes – trust and inefficiency – and drivers of success – demonstrat-
ing value and leadership (see Figures 1 and 2).
In our discussions, we encountered a general sense of concern about the present 
ethics review system, which has also been expressed in the literature (e.g. Ferguson 
and Master, 2016). This said, all participants were of the opinion that ethics review 
is a critical component of research involving humans (even if such research only 
involves humans indirectly) and should not be seen by researchers as merely a 
hurdle to get past.
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Figure 2. Addressing the problem of systemic inefficiency.
Figure 1. Addressing the problems of lack of trust and apprehension to novel science.
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The foremost concern was systemic inefficiencies that neither provided added 
protection to participants nor promotion of research interests. This sentiment 
accords with recent literature, which has similarly expressed concern about the 
emphasis on ‘protection ethics’ rather than the ethical value of research (Whitney, 
2016). Indeed, despite the many problems identified by participants with the extant 
ethics review system for international data-intensive research, and the challenges to 
reforming the system, most expressed optimism that change is possible to enable 
ethics review ‘mutual recognition’ that promotes efficiency in review and main-
tains robust protection of the rights, interests and welfare of participants. Three 
models of mutual recognition recently proposed (Dove et al., 2016) were supported 
by different participants as potential solutions to the problems identified; these 
models were either referenced as having been implemented in a specific project, or 
in a future model that could be pilot-tested. Data are emerging in the literature that 
suggest there is some success in these models for improving efficiencies in review 
in other research domains (e.g. cancer trials) without compromising participant 
protection – at least on a national level so far (Wagner et al., 2010).
A few participants were sceptical of systemic reform – particularly those in 
Europe with experience in EU policy-making. A few suggested that at least one 
full REC review should be undertaken in each relevant country, though some were 
open to the idea of regional REC review, e.g. an ‘EU REC’ in Brussels. Most advo-
cated that greater information-sharing between RECs in different jurisdictions 
should occur so that reviews between them could be informed by the other; this 
would be an improvement that need not require a completely different model of 
ethics review. Several participants also stressed that RECs are only one (albeit 
important) component in data-intensive research (McDonald et al., 2011). In the 
data-intensive research context, other actors such as data access committees, 
funders, institutions, regulatory authorities, and privacy/data protection authorities 
and officers also must be brought into discussions about systemic reform.
This is seen as a particularly important issue within data-intensive research, as 
some express concern that data-sharing is less ‘REC-impeded’ than it is privacy-
officer impeded, and that data privacy legislation is disharmonized across jurisdic-
tions and interpreted by privacy officers at different authorities or institutions in 
rather different ways (Dove and Phillips, 2015). For these participants, concerns 
about an inefficient ethics review system stretched to concerns about research 
governance processes for data-intensive research (and data-sharing) as a whole 
(Shabani and Borry, 2016; Shabani et al., 2015).
Regarding the seemingly intractable challenge of local context and sensitivities, 
several participants suggested that this could be addressed through community 
engagement exercises and in separating research ethics issues from research gov-
ernance issues. For example, one interviewee discussed how a federated REC 
operating in a jurisdiction still permits local sites (institutions such as hospitals) to 
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have a role to play in considering local aspects, where they can submit ‘centre-
specific’ applications once the main jurisdiction-wide application has been 
reviewed and approved. This mechanism is seen to give institutions the chance to 
do tweaking and provide local input on governance matters, which reduces dupli-
cation and inefficiencies in the ethics review(s).
Finally, trust was an overarching theme that permeated the discussion as both a 
problem and challenge: trust in the robustness of procedures (i.e. of RECs in each 
other); trust in REC decision-making; trust that the proposed research carries social 
value; and trust by overseeing regulatory authorities that the ethics review proce-
dures in other countries are equally robust and equally well resourced and diligent. 
Participants stressed that developing trust between jurisdictions is extremely diffi-
cult, particularly in regions that are economically disadvantaged, where laws are 
non-existent or weakly enforced, and where historically there has been war, civil 
strife and exploitation (e.g. in Africa). These statements align with research ethics 
scholars who argue that greater dialogue is needed amongst different actors in the 
research ecosystem to promote inter-REC trust (Aultman, 2014), which may be 
accomplished through mechanisms like joint (or federated) ethics review collabo-
ration (Dauda and Dierickx, 2014; Meslin et al., 2014). Thus, in order to work 
towards mutual recognition, one must first think about the boundary conditions to 
establish trust such that one REC can rely on another’s review and decision.
Conclusion
The aim of this qualitative research project was to gather perspectives on real-life 
experiences with navigating ethics review of multi-jurisdictional data-intensive 
research projects, problems that arise in the course of this navigation, and how these 
problems can be effectively addressed, if at all. In this article, we highlighted the 
themes of systemic inefficiency and trust, as well as various problems, solutions and 
challenges in building a system of ethics review mutual recognition. This system can 
be designed through various models built on the dual tenets of demonstrating value 
and leadership (both bottom-up and top-down). Future studies should explore the 
niche area findings such as: the ‘challenge’ of addressing local context; the possibil-
ity of tailoring ethics review mutual recognition models depending on the sensitivity 
of the data to be collected; specific tools to foster trust between RECs and institu-
tions; metrics to measure the quality of REC review (Nicholls et al., 2015); the dif-
ficulties associated with jurisdictional sovereignty, politics and regulation; and the 
notion of ‘power’ amongst different actors (institutions, RECs, regulators, sponsors 
and researchers) and how it impacts on ethics review (Hemminki, 2015).
Whilst many of the problems identified by participants have been known and 
discussed for years, as has the theme of systemic inefficiency, we share our partici-
pants’ belief that we are at an ‘inflection point’ for change, and share optimism for 
various ways forward for short-term gain, as well as long-term solutions. In this 
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sense, there appear to be recent promising avenues for systemic reform. The 
GA4GH has developed an ‘Ethics Review Recognition Policy’ document to foster 
recognition of extra-jurisdictional ethics reviews and improve the consistency 
thereof, as well as to promote efficient and responsible health-related data sharing 
for human health and wellbeing. The policy could perhaps eventually be expanded 
to other types of international biomedical research.4 A similar but broader initia-
tive has been undertaken by the WHO (World Health Organization, 2011). Whilst 
a policy obviously cannot address more structural issues such as laws and mone-
tary resources for RECs, it can establish a baseline for building trust in the pro-
cesses undertaken by RECs in different jurisdictions, including in parts of the 
world that would want assurances that subsequent data uses for research would not 
lead to further disempowerment of local scientists and populations.
Also, participants pointed to successful existing initiatives in several jurisdic-
tions that incorporate elements of mutual recognition, including: Clinical Trials 
Ontario; the Ontario Cancer Research Ethics Board (OCREB); the NIH’s move to 
require use of a single institutional review board for multi-site research in the US 
(National Institutes of Health, 2016) and a similar initiative in the US federal gov-
ernment (Federal Register, 2017); and the Australian federal government’s 
National Approach to Single Ethical Review of Multi-centre Research. The logical 
and achievable next step would be to scale up these existing initiatives extra-juris-
dictionally. With Clinical Trials Ontario, it could mean working to achieve mutual 
recognition with an ethics committee in neighbouring Quebec or Manitoba; in 
Australia, it could mean pilot testing mutual recognition with an ethics committee 
in New Zealand. Research consortia may also, in consultation with relevant com-
petent regulatory authorities, seek to pilot test a different type of mutual recogni-
tion model and determine its effectiveness even between two neighbouring and 
trusted jurisdictions (e.g. US and Canada or Norway and Sweden). There is also a 
role for international and regional bodies such as the WHO, GA4GH, UNESCO, 
EU and the European Network of Research Ethics Committees (EUREC) to play. 
We believe that these organizations have the legitimacy, expertise and authority to 
bring various actors together to share best practices and knowledge, foster trust, 
and work to design or endorse frameworks of mutual recognition.
At the same time, science groups, sponsors, funders and research consortia 
should continue to demonstrate leadership on the ground by developing innovative 
solutions to ethics review and sharing lessons learnt to develop best practices in 
areas such as conditions for release of data and data access procedures. Regulatory 
authorities can and should do more to encourage institutions and research organiza-
tions to use mutual recognition models when appropriate. Finally, we advocate 
longer-term orientated solutions such as: continued building of national and regional 
ethics committee networks and structures that can be integrated into an interna-
tional network to build communication and trust; greater capacity building of RECs 
(particularly in LMICs); the development of internationally supported certification 
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or accreditation processes for RECs and/or REC members to improve overall qual-
ity and trust; the development of interoperable IT systems for sharing research 
application-related documents (including an HTML-based standard research appli-
cation form and an online application portal), REC opinions and registries of 
approved projects; greater separation of ethics issues from governance issues/
empirical questions (e.g. local participant recruitment, site suitability, investigator 
competence), the latter of which should be addressed by local, non-REC bodies; 
further harmonization of regulation in areas such as data protection and in under-
standings of consent or authorization for using data for research purposes; and more 
international research ethics meetings to stimulate in situ dialogue on substantive 
ethics issues and harmonization of processes.
A deeper question remains, however: if we work to achieve harmonization of 
procedure and thus mutual recognition of ethics review, is it necessary, possible or 
desirable to achieve a harmonized substantive ethics as well? In other words, can 
we achieve a universal language of ethics (which, as with most languages, will 
carry local dialects and accents) both across RECs and also embodied in research-
ers? We leave this question for a future research project, but with respect to proce-
dural harmonization of ethics review our crucial finding from this project is that 
this task is difficult, but desirable.
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Notes
1. We define ‘international data-intensive research’ as cross-border multi-site research using 
computation of multiple sources and volumes of data. The focus of our project is on data-
intensive research in the life sciences domain, i.e. research making use of genomic, clini-
cal and other health-related data.
2. http://genomicsandhealth.org.
3. As outlined in Dove et al. (2016), in the reciprocity model, an institution, funder, or regu-
lator/government in one jurisdiction accepts the completed ethics review from another 
jurisdiction and vice versa through collaborative recognition of equivalent processes 
and/or standards. In the delegation model, before ethics review, an institution, funder or 
regulator/government delegates ethics review responsibilities to one or several existing 
designated RECs through agreement. In the federation model, institutions, funders or reg-
ulators/governments create a central REC with representation from multiple jurisdictions.
4. https://genomicsandhealth.org/work-products-demonstration-projects/ethics-review-rec-
ognition-policy (accessed 18 May 2017).
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